pharma-company /Medicinal products /Active ingredients

Rx · PZN 05515513, 05515542, 15317553

RESTEX 100 mg/25 mg hard capsules prolonged-release

German trade nameRESTEX 100 mg-25 mg Hartkapseln retardiert

Active ingredientLevodopa and decarboxylase inhibitorSubstance (DE)Levodopa und Decarboxylasehemmer*Pharmaceutical formRectal capsules

Consistently available

9.6

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Extended ambient max. 30 °C

Average purchase price (B2B)

~ €18

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

RESTEX 100 mg/25 mg hard capsules prolonged-release is consistently available through wholesale. We are happy to review your purchase price and advise you on it.

Review purchasing terms

RESTEX 100 mg/25 mg hard capsules prolonged-release contains the active ingredient Levodopa and decarboxylase inhibitor (German Levodopa und Decarboxylasehemmer*) and comes as Rectal capsules. 3 pack sizes of this product are recorded. All packs reach a pharma availability index of 9.6 out of 10 over the past 30 days.


Pack sizes · 3 PZN

PZNIndex 7 dIndex 30 d Highest known purchase price
055155139.49.6~ €5
055155429.49.6~ €26
153175539.49.6~ €24

We are happy to advise you on sources of supply, purchase prices and procurement optimisation for your pharmaceutical wholesale business or your pharmacy.

Get in touch

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. The average purchase price was calculated across all 3 recorded PZNs.